Hormosan Pharma Overview

  • Founded
  • 1968
  • Status
  • Acquired/​Merged
  • Employees
  • 56
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Hormosan Pharma General Information


Developer of generic pharmaceutical products designed to improve medication compliance. The company designs, develops and supplies pharmaceutical products for the central nervous system that offer additional benefits in terms of therapy relevance.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Parent Company
Primary Office
  • P.O. Box 60 03 40
  • 60333 Frankfurt
  • Germany
+49 069 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hormosan Pharma Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hormosan Pharma‘s full profile, request access.

Request a free trial

Hormosan Pharma Executive Team (4)

Name Title Board Seat Contact Info
Werner Schneider Ph.D Joint Managing Director
Thierry Volle Managing Director
Sofia Mumtaz Ph.D Executive
Ramesh Swaminathan Joint Managing Director
To view Hormosan Pharma’s complete executive team members history, request access »

Hormosan Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial